Re:Theranos Founder Elizabeth Holmes Is Denied a Bid for New...
by vkou on Tuesday November 08, 2022 @01:50PM
(#33522709)
> In business terms it's a win, but not very much for the public.
It's a win for the public, because the public cost in medical bills, insurance claims, medicare, suffering, and death from vaccine hesitancy far outweighs the cost of highly infrequent payouts.
It's a win for the public, because the public cost in medical bills, insurance claims, medicare, suffering, and death from vaccine hesitancy far outweighs the cost of highly infrequent payouts.